172 related articles for article (PubMed ID: 14601519)
21. [Gene therapy for immune deficiencies].
Fischer A; Hacein-Bey S; Le Deist F; de Saint Basile G; de Villartay JP; Cavazzana-Calvo M
Bull Acad Natl Med; 2000; 184(7):1417-28; discussion 1428-30. PubMed ID: 11261248
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of simian/human immunodeficiency virus replication in CD4+ T cells derived from lentiviral-transduced CD34+ hematopoietic cells.
Braun SE; Wong FE; Connole M; Qiu G; Lee L; Gillis J; Lu X; Humeau L; Slepushkin V; Binder GK; Dropulic B; Johnson RP
Mol Ther; 2005 Dec; 12(6):1157-67. PubMed ID: 16168713
[TBL] [Abstract][Full Text] [Related]
23. Novel strategies for the selection of cells expressing human adenosine deaminase and their application in experimental gene therapy protocols.
Shen Q; Van Beusechem VW; Hendrikx PJ; Valerio D
Allergol Immunopathol (Madr); 1991; 19(1):29-31. PubMed ID: 1659164
[No Abstract] [Full Text] [Related]
24. Prospects for gene therapy of human disease.
Blaese RM; Culver KW
Allergol Immunopathol (Madr); 1991; 19(1):25-8. PubMed ID: 1683140
[No Abstract] [Full Text] [Related]
25. Gene therapy: here to stay.
Dubé ID; Cournoyer D
CMAJ; 1995 May; 152(10):1605-13. PubMed ID: 7743447
[TBL] [Abstract][Full Text] [Related]
26. French gene therapy group reports on the adverse event in a clinical trial of gene therapy for X-linked severe combined immune deficiency (X-SCID). Position statement from the European Society of Gene Therapy.
European Society of Gene Therapy
J Gene Med; 2003 Jan; 5(1):82-4. PubMed ID: 12516054
[No Abstract] [Full Text] [Related]
27. Gene therapy for childhood immunological diseases.
Kohn DB
Bone Marrow Transplant; 2008 Jan; 41(2):199-205. PubMed ID: 17994122
[TBL] [Abstract][Full Text] [Related]
28. [Cell therapy for inherited diseases of the hematopoietic system].
Cavazzana-Calvo M; Dal-Cortivo L; André-Schmutz I; Hacein-Bey Abina S; Fischer A
C R Biol; 2007; 330(6-7):538-42. PubMed ID: 17631450
[TBL] [Abstract][Full Text] [Related]
29. [Gene therapy of severe combined immunodeficiency disease: proof of principle of efficiency and safety issues. Gene therapy, primary immunodeficiencies, retrovirus, lentivirus, genome].
Fischer A; Hacein-Bey-Abina S; Lagresle C; Garrigue A; Cavazana-Calvo M
Bull Acad Natl Med; 2005 May; 189(5):779-85; discussion 786-8. PubMed ID: 16433450
[TBL] [Abstract][Full Text] [Related]
30. Primary immune deficiencies unravel the molecular basis of immune response.
Notarangelo LD; Giliani S; Mazzolari E; Gulino AV
Rev Clin Exp Hematol; 2003 Mar; 7(1):84-111. PubMed ID: 14692236
[TBL] [Abstract][Full Text] [Related]
31. Molecular defects in T- and B-cell primary immunodeficiency diseases.
Cunningham-Rundles C; Ponda PP
Nat Rev Immunol; 2005 Nov; 5(11):880-92. PubMed ID: 16261175
[TBL] [Abstract][Full Text] [Related]
32. Gene Therapy for the Treatment of Primary Immune Deficiencies.
Kuo CY; Kohn DB
Curr Allergy Asthma Rep; 2016 May; 16(5):39. PubMed ID: 27056559
[TBL] [Abstract][Full Text] [Related]
33. Allogeneic hematopoietic stem cell transplantation for seven children with X-linked hyper-IgM syndrome: a single center experience.
Tomizawa D; Imai K; Ito S; Kajiwara M; Minegishi Y; Nagasawa M; Morio T; Nonoyama S; Mizutani S
Am J Hematol; 2004 May; 76(1):33-9. PubMed ID: 15114594
[TBL] [Abstract][Full Text] [Related]
34. [Present status and future prospects of human gene therapy].
Shimada T
Nihon Kyobu Shikkan Gakkai Zasshi; 1993 Dec; 31 Suppl():1-4. PubMed ID: 8007452
[TBL] [Abstract][Full Text] [Related]
35. [Gene therapy in primary immunologic failure].
Frøland SS
Tidsskr Nor Laegeforen; 2001 Jan; 121(3):351-4. PubMed ID: 11242882
[TBL] [Abstract][Full Text] [Related]
36. Gene therapy: panacea or placebo? II. Main applications of gene therapy.
Górecki DC; MacDermot KD
Arch Immunol Ther Exp (Warsz); 1997; 45(5-6):375-81. PubMed ID: 9437493
[TBL] [Abstract][Full Text] [Related]
37. Gene therapy for primary immunodeficiencies: Part 1.
Cavazzana-Calvo M; Fischer A; Hacein-Bey-Abina S; Aiuti A
Curr Opin Immunol; 2012 Oct; 24(5):580-4. PubMed ID: 22981681
[TBL] [Abstract][Full Text] [Related]
38. [Current clinical immunology: a genetic and molecular perspective].
Carrión F; Figueroa FE; Rodríguez C
Rev Med Chil; 2000 Jun; 128(6):650-8. PubMed ID: 11016066
[TBL] [Abstract][Full Text] [Related]
39. Stem cell gene transfer: insights into integration and hematopoiesis from primate genetic marking studies.
Dunbar CE
Ann N Y Acad Sci; 2005 Jun; 1044():178-82. PubMed ID: 15958711
[TBL] [Abstract][Full Text] [Related]
40. Perspectives of gene therapy for primary immunodeficiencies.
Chinen J; Puck JM
Curr Opin Allergy Clin Immunol; 2004 Dec; 4(6):523-7. PubMed ID: 15640693
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
